Physician profile
Sarah Sercombe
NPI 1992244768
$824.37
in general payments reported to CMS, 2019-2025
14 companies · $155 in 2025
The $155 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $216 · 2022: $235 · 2023: $159 · 2024: $59.24 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $315.58 | 2021-2023 | Auvi-Q |
| Pfizer INC. | $120.56 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $68.43 | 2021-2023 | Vaxneuvance, Vaxelis, Vaqta |
| Alk-Abello, INC | $56.03 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $50.26 | 2024-2025 | |
| Sanofi Pasteur INC. | $40.41 | 2021-2022 | |
| Sobi, INC | $29.10 | 2022-2023 | |
| Cipher Pharmaceuticals US LLC | $24.70 | 2025 | Natroba, Spinosad |
| Ironshore Pharmaceuticals INC. | $21.44 | 2024 | |
| Cranial Technologies, INC | $21.14 | 2024 | Doc Band |
| Verrica Pharmaceuticals INC. | $21.10 | 2025 | Ycanth |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.85 | 2023 | Xifaxan |
| Lnhc, INC | $20.00 | 2025 | Zelsuvmi |
| Takeda Pharmaceuticals U.S.A., INC. | $14.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Sercombe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.